NYSE:AMPE Investor Notice: Lawsuit Alleges Securities Laws Violations by Ampio Pharmaceuticals, Inc.
An investor, who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE), filed a lawsuit over alleged violations of Federal Securities Laws by Ampio Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements.
View full press release